Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharmalogic IT & Automation ApS
APS
Active
CVR 44361086
Brunemarksvej 17
Computer consultancy and computer facilities management activities · NACE 6220
Est. 2023
6 employees
www.pharmalogic.dk
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 7,8M
EBITDA margin
22.2%
Equity ratio
49.3%
Financial strength
Net profit 2024
DKK 1,4M
6 employees
EBITDA — year on year
DKK millions
3M
2M
1M
1M
0M
2M
2024
Key figures
Annual report 2024
Revenue
DKK 7,8M
—
EBITDA
DKK 1,7M
—
Net profit
DKK 1,4M
—
Total assets
DKK 2,8M
—
Equity
DKK 1,4M
—
Employees
6
—
Company information
Legal name
Pharmalogic IT & Automation ApS
CVR number
44361086
Legal form
Anpartsselskab
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
9. oktober 2023
Share capital
DKK 40.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Brunemarksvej 17
Phone
+4541564189
Email
thomas.vestergaard@pharmalogic.dk
Website
www.pharmalogic.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computer consultancy and computer facilities management activities
Companies in Fredensborg
All Denmark companies
Revenue
DKK millions
0M
2M
5M
7M
9M
8M
2024
EBITDA
DKK millions
0M
1M
1M
2M
2M
2M
2024
Income statement
DKK thousands
Item
2024
Revenue
7.834
Staff expenses
-6.091
EBITDA
1.743
Depreciation & amort.
0
EBIT
1.743
Net financials
1
Profit before tax
1.744
Tax
389
Net profit
1.354
Balance sheet
DKK thousands
Item
2024
Total assets
2.826
Equity
1.394
Long-term debt
0
Short-term debt
1.431
Total debt
1.431
Financial ratios
5-year trend
EBITDA margin
22.2%
This company
15.8%
Market median
+41% vs market
2024
2024
Equity ratio
49.3%
This company
38.2%
Market median
+29% vs market
2024
2024
Return on equity
97.1%
This company
18.4%
Market median
+428% vs market
2024
2024
Net profit margin
17.3%
This company
8.1%
Market median
+114% vs market
2024
2024
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
2024
2024
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-10-09 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (3)
TD
Tanja Dybdal Beck
Management
Management
2023
TV
Thomas Vestergaard
Chief Executive Officer
Chief Executive Officer
2023
AC
Allan Christian Beck
Management
Management
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
DYBDAL BECK INVEST ApS
Company
50–66.65%
50–66.65%
2023
Agera Invest ApS
Company
50–66.65%
50–66.65%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
DYBDAL BECK INVEST ApS
Pharmalogic IT & Automation ApS
(this company)
Board network connections
Board members of Pharmalogic IT & Automation ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Tanja Dybdal Beck
Management
0 companies
Thomas Vestergaard
Chief Executive Officer
0 companies
Allan Christian Beck
Management
0 companies